Related Experiment Video

Updated: Jul 13, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Combined antiplatelet and anticoagulant therapy: clinical benefits and risks

J W Eikelboom1, J Hirsh

  • 1Thrombosis Service, Hamilton General Hospital, Hamilton, ON, Canada. eikelbj@mcmaster.ca

Journal of Thrombosis and Haemostasis : JTH
|August 1, 2007
PubMed

Insights

Combining anticoagulant and antiplatelet therapy improves acute coronary syndrome management but raises bleeding risks. For atrial fibrillation patients, switching to anticoagulants may suffice, avoiding combined therapies unless necessary.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Combination anticoagulant and antiplatelet therapy is effective for acute coronary syndromes (ACS) but increases bleeding risk.
  • Use of oral anticoagulants with antiplatelet therapy in patients with both atrial fibrillation and coronary artery disease is common but controversial.
  • Anticoagulation alone is effective for long-term management of ACS, stroke, and peripheral artery disease, though with higher bleeding risk.

Purpose of the Study:

  • To evaluate the appropriateness and efficacy of combined anticoagulant and antiplatelet therapy versus alternatives in specific patient populations.
  • To determine if switching from antiplatelet therapy to anticoagulants is sufficient for atrial fibrillation patients post-ACS.
  • To assess the benefit-risk profile of triple therapy in patients with atrial fibrillation and coronary stents.

Main Methods:

  • Review of existing evidence on combination anticoagulant and antiplatelet therapies.
  • Comparative analysis of anticoagulation versus antiplatelet therapy for long-term management of cardiovascular conditions.
  • Examination of specific drug combinations (aspirin, clopidogrel, warfarin) in different clinical scenarios.

Main Results:

  • Combined therapy offers benefits in acute coronary syndromes but increases bleeding.
  • Anticoagulation alone is comparable to antiplatelet therapy for long-term management of ACS, stroke, and PAD.
  • Combination therapy provides proven benefit over anticoagulants only in prosthetic heart valve patients.
  • Aspirin plus clopidogrel is less effective than oral anticoagulants for atrial fibrillation but more effective for coronary stents.

Conclusions:

  • In patients with atrial fibrillation and ACS, switching to anticoagulants may be adequate, avoiding combined therapy risks.
  • Triple therapy (anticoagulant plus dual antiplatelets) benefit over anticoagulants alone is limited to specific indications like prosthetic heart valves.
  • Randomized trials are needed to clarify the risks and benefits of triple therapy in patients with both atrial fibrillation and coronary stents.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...